This book critically reviews 75 important published papers that influence the practice of geriatric psychiatry. This book will assist anyone who is interested in the care of older adults with psychiatric disorders. It was written by thought leaders who shape the way geriatric psychiatry is currently practiced in the United States. All the major psychiatric disorders in later life are covered including anxiety disorders, bipolar disorders, depressive disorders, neurocognitive disorders, psychotic disorders, sleep disorders, and substance use disorders. It also reviews important studies on suicides in late life and interventional procedures in geriatric psychiatry like the ECT, and also evaluates the adverse effects of psychotropic medications on older adults with psychiatric disorders.
The editors of the book along with input from members of the teaching and training committee of the American Association for Geriatric Psychiatry (AAGP) have chosen 75 published papers from the field of geriatric psychiatry that they believe provides the highest knowledge-yield/impact for practicing clinicians and educators in the field of geriatric mental health. The AAGP is a national association that represents and serves its members and the field of geriatric psychiatry. These 75 papers are critically appraised by the members of AAGP using a standardized format and a summary of these papers and their practical application is provided by these experts. This information can be used by anyone who wants to learn about the field of geriatric psychiatry.
Section 1: Adverse effects of medications.- Do atypical antipsychotics
cause stroke?.- Risk of death with atypical antipsychotic drug treatment for
dementia: meta-analysis of randomized placebo-controlled
trials.- Meta-analysis of the Impact of 9 Medication Classes on Falls in
Elderly Persons.- The efficacy and safety of atypical antipsychotics for the
treatment of dementia: a meta-analysis of randomized placebo-controlled
trials.- Do antipsychotics lead to cognitive impairment in dementia? A
meta-analysis of randomised placebo-controlled trials.- A Systematic Review
and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use,
After Controlling for Protopathic Bias.- Section 2: Anxiety
Disorders.- Treatment of panic disorder in older adults: a pilot study
comparison of alprazolam, imipramine, and placebo.- Efficacy and tolerability
of citalopram in the treatment of late-life anxiety disorders: results froman
8-week randomized, placebo-controlled trial.- Efficacy and tolerability of
duloxetine in elderly patients with generalized anxiety disorder: a pooled
analysis of four randomized, double-blind, placebo-controlled
studies.- Escitalopram for older adults with generalized anxiety disorder: a
randomized controlled trial.- Meta-analysis Comparing Different Behavioral
Treatments for Late-Life Anxiety.- Cognitive Behavior Therapy for Generalized
Anxiety Disorder Among Older Adults in Primary Care: A Randomized Clinical
Trial.- Stepped-care prevention of anxiety and depression in late life: a
randomized controlled trial.- A randomized controlled study of paroxetine and
cognitive-behavioural therapy for late-life panic disorder.- Antidepressant
medication augmented with cognitive-behavioral therapy for generalized
anxiety disorder in older adults.- A meta-analysis of cognitive functioning
in older adults with PTSD.- Anxiety as a Predictor for Cognitive Decline and
Dementia: A Systematic Review and Meta-Analysis.- Section 3: Bipolar
Disorder.- A Pilot Study of Standardized Treatment in Geriatric Bipolar
Disorder.- Differences in clinical features and mental health service use in
bipolar disorder across the lifespan.- Effect of antidepressant use on
admissions to hospital among elderly bipolar patients.- GERI-BD: A Randomized
Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of
Mania in Older Patients With Bipolar Disorder.- History of Bipolar disorder
and the risk of dementia: A systematic review and meta-analysis.- Section
4.
Delirium.- A Multicomponent Intervention to Prevent Delirium in Hospitalized
Older Patients.- Delirium in elderly patients and the risk of post discharge
mortality, institutionalization, and dementia: a
meta-analysis.- Effectiveness of multicomponent nonpharmacological delirium
interventions: a meta-analysis.- Antipsychotic Medication for Prevention and
Treatment of Delirium in Hospitalized Adults: A Systematic Review and
Meta-Analysis.- Interventions for preventing delirium in older people in
institutional longterm care.- Section 5: Depressive
Disorders.- Nortriptyline and Interpersonal Psychotherapy as Maintenance
Therapies for Recurrent Major Depression. A Randomized Controlled Trial in
Patients Older Than 59 Years.- Continuation treatment of delusional
depression in older adults.- Reducing suicidal ideation and depressive
symptoms in depressed older primary care patients: a randomized controlled
trial.- Remission in Depressed Geriatric Primary Care Patients: A Report from
the PROSPECT Study.- Executive dysfunction and the course of geriatric
depression.- Maintenance Treatment of Major Depression in Old
Age.- Placebo-Controlled Study of Relapse Prevention With Risperidone
Augmentation in Older Patients with Resistant Depression.- Efficacy of
Second-Generation Antidepressants in Late-Life Depression: A Meta-Analysis of
the Evidence.- A double-blind randomized controlled trial of olanzapine plus
sertraline vs olanzapine plus placebo for psychotic depression: the study of
pharmacotherapy of psychotic depression (STOP-PD).- Speed of remission in
elderly patients with depression: electroconvulsive therapy v. medication.- A
systematic review and meta-analysis of psychotherapy for late-life
depression.- A novel strategy for continuation ECT in geriatric depression:
phase 2 of the PRIDE Study.- Right Unilateral Ultrabrief Pulse ECT in
Geriatric Depression: Phase 1 of the PRIDE Study.- Improvement in Depression
is Associated with Improvement in Cognition in Late-Life Psychotic
Depression.- Section 6: Electroconvulsive Therapy.- Continuation/Maintenance
Treatment with Nortriptyline Versus Combined Nortriptyline and ECT in
Late-Life Psychotic Depression: A Two-Year Randomized Study.- Safety and
utility of acute electroconvulsive therapy for agitation and aggression in
dementia.- Electroconvulsive therapy and risk of dementia in patients with
affective disorders: a cohort study.- Electroconvulsive Therapy and Risk of
Dementia-A Nationwide Cohort Study in Taiwan.- Section 7: Grief.- Treatment
of complicated grief in elderly persons: a randomized clinical
trial.- Section 8: Pain Disorders.- Association Between Psychological
Interventions and Chronic Pain Outcomes in Older Adults: A Systematic Review
and Meta-Analysis.- Section 9: Psychotic Disorders.- A Randomized, Controlled
Trial of Cognitive Behavioral Social Skills Training for Middle-Aged and
Older Outpatients with Chronic Schizophrenia.- Safety and tolerability of
oral paliperidone extended-release tablets in elderly patients with
schizophrenia: a double-blind, placebo-controlled study with six-month
open-label extension.- Antipsychotic treatment for elderly people with
late-onset schizophrenia.- Schizophrenia and risk of dementia: A
meta-analysis study.- Antipsychotic treatment of very late-onset
schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind
trial.- Section 10: Neurocognitive Disorders.- Efficacy and safety of
cholinesterase inhibitors in Alzheimer's disease: a
meta-analysis.- Depression and risk for Alzheimer disease: Systematic review,
Meta-analysis, and Metaregression analysis.- Effectiveness of atypical
antipsychotic drugs in patients with Alzheimers disease.- Predictors of
progression from mild cognitive impairment to Alzheimer disease.- Efficacy
and safety of cognitive enhancers for patients with mild cognitive
impairment: a systematic review and meta-analysis.- Personality and risk of
Alzheimers disease: New data and meta-analysis.- Modifiable predictors of
dementia in mild cognitive impairment: a systematic review
andmeta-analysis.- Pharmacological Management of Lewy Body Dementia: A
Systematic Review and Meta-Analysis.- Meta-analysis of modifiable risk
factors for Alzheimers disease.- Memantine for Alzheimer's Disease: An
Updated Systematic Review and Meta-analysis.- Update on the Risk of Motor
Vehicle Collision or Driving Impairment with Dementia: A Collaborative
International Systematic Review and Meta-Analysis.- Pharmacological
interventions for apathy in Alzheimer's disease.- Section 11: Sleep
Disorders.- Behavioral and Pharmacological Therapies for Late-Life Insomnia:
A Randomized Controlled Trial.- Cognitive behavioral therapy vs zopiclone for
treatment of chronic primary insomnia in older adults: a randomized
controlled trial.- Suvorexant in Elderly Patients with Insomnia: Pooled
Analyses of Data from Phase III Randomized Controlled Clinical
Trials.- Cognitive behavior therapy for older adults with insomnia and
depression: a randomized controlled trial in community mental health
services.- Section 12: Suicides.- Medical Illness and the Risk of Suicide in
the Elderly.- The Risk of Suicide with Selective Serotonin Reuptake
Inhibitors in the Elderly.- Section 13: Substance Use Disorders.- Naltrexone
as an Adjunctive Treatment for Older Patients with Alcohol Dependence.- Older
adult patients with both Psychiatric and Substance abuse disorders:
Prevalence and Health service use.- Five-year alcohol and drug treatment
outcomes of older adults versus middle-aged and younger adults in a managed
care program.- Treatment of Late-Life Depression Complicated by Alcohol
Dependence.- Screening and Brief Intervention for Substance Misuse Among
Older Adults: The Florida BRITE Project.
Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP, Creighton University School of Medicine, Department of Psychiatry, Creighton, NE
Dr. Tampi is the Professor and Chairman of the Department of Psychiatry at Creighton University School of Medicine, Omaha, Nebraska. He is also the Chairman of Catholic Health Initiatives (CHI) Behavioral Health Services, Omaha, Nebraska. Dr. Tampi maintains his appointment as an Adjunct Professor of Psychiatry at Yale School of Medicine, New Haven, Connecticut. He is a Past President of the American Association for Geriatric Psychiatry (AAGP).
Deena J. Tampi, MSN, MBA-HCA, RN, DFAAGP, Behavioral Health Advisory Group, Princeton, NJ, USA
Ms. Tampi is the Co-Founder and Managing Principal, Behavioral Health Advisory Group, Princeton, New Jersey. Ms. Tampi is on the Board of Directors for the American Association for Geriatric Psychiatry. In addition, she is the Chairperson of the Membership Committee for the American Association for Geriatric Psychiatry.
Juan J. Young, MD, Yale School of Medicine, Geriatric Psychiatry, New Haven, CT
Dr. Young is a current Geriatric Psychiatry Fellow at the Yale School of Medicine, and he also serves in the AAGP Membership Committee.
Meera Balasubramaniam, MD, MPH, NYU Langone Health, Department of Psychiatry, New York, NY
Dr. Meera Balasubramaniam is a Clinical Assistant Professor and the Director of the Geriatric Psychiatry fellowship program at the New York University School of Medicine. She has served on the editorial board of Frontiers in Psychiatry, is an Associate member on the editorial board of the American Journal of Geriatric Psychiatry
Pallavi Joshi, DO, MA University of Arizona College of Medicine-Phoenix, Phoenix, AZ
Dr. Pallavi Joshi is a Clinical Assistant Professor at University of Arizona College of Medicine-Phoenix and a geriatricpsychiatrist at Banner Alzheimer's Institute. She has served on the Board of Directors for the American Association for Geriatric Psychiatry and the Council of Geriatric Psychiatry for the American Psychiatric Association.
